City
Epaper

Section 144 extended in Noida till May 31

By IANS | Updated: May 20, 2020 19:35 IST

The Gautam Buddh Nagar district in Uttar Pradesh, which falls in the Red Zone category, on Wednesday extended the ...

Open in App

The Gautam Buddh Nagar district in Uttar Pradesh, which falls in the Red Zone category, on Wednesday extended the prohibitory orders barring the assembly of four or more people, in the district till May 31 in the wake of the nationwide lockdown to combat the Covid-19 pandemic.

Earlier, the Criminal Procedure Code (CrPC) Section 144 was in force in the district till May 17. However, it was extended on Wednesday keeping in view the number of cases. On Tuesday, the district had reported three new cases.

"Those who flout the norms will be punished under Section 188 (Disobedience to order duly promulgated by public servant) of the Indian Penal Code (IPC)," said Gautam Buddh Nagar Additional Commissioner of Police (Law and Order).

As of Tuesday, 289 confirmed cases of coronavirus have been recorded in the district, including five deaths, while 207 patients have recovered and got discharged from the hospitals, according to official figures.

( With inputs from IANS )

Open in App

Related Stories

BusinessUS, European stock markets tumble on Trump's tariff move; Amazon & Apple shares face heavy selling

InternationalIndia-UN launch first phase of global capacity-building projects to boost South-South cooperation

InternationalKabul residents decry worsening power outages, demand urgent action

NationalIndia-UN launch first phase of global capacity-building projects to boost South-South cooperation

FootballISL: Foreigners who returned to the League after a break

Health Realted Stories

HealthTripura govt planning to conduct heart transplants in state hospitals: CM Saha

HealthSouth Korea: Seoul sets record 23 tropical nights for July

HealthIndian scientists develop new approach for treatment of liver cirrhosis

HealthOver Rs 10 cr spent for prevention of zoonotic diseases in FY 25: Govt

HealthPhase III clinical trial for India’s 1st dengue vaccine hits 70pc enrolment mark: Minister